Orange Book product · Generic (ANDA)
ZAFIRLUKAST
ZAFIRLUKAST
Generic (ANDA)ANDA 204928TE ABRX RISING PHARMS
At a glance
Aug 25, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 25, 2022
3 yr 10 mo ago
Today
Pharmaceutical detail
Active ingredient
ZAFIRLUKAST
Strength
10MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 204928
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ZAFIRLUKAST
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
